Company intelligence / Profile preview

Cepter Biopartners

Nutley, New Jersey, United Statescepterbiopartners.com ↗

Ownership: Private
Development stage: Other

Overview

Cepter Biopartners does not develop its own therapeutics but provides expert molecular biology, protein biochemistry, and assay development services to support clients’ drug discovery from target identification through lead optimization. The company’s leadership has extensive big pharma experience and offers both laboratory execution and strategic project planning.

Modalities: Protein (recombinant protein production and purification)Assay development (service modality, not a therapeutic)Molecular biology services (service modality)Small molecule screening support (enabling service for small molecules)
Industry: Drug Discovery Services

Partnerships

Hoffmann-La Roche Inc. (spinout relationship; initial contracts)Bill & Melinda Gates Foundation

Beyond the preview

Go deeper on Cepter Biopartners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cepter Biopartners.

Explore the full profile